Tecan appoints Ulrich Kanter to the Management Board - Seite 2
From 1995 to 2000, Ulrich Kanter was Vice President Operations and Global Supply Chain Manager at AVL Medizintechnik, with responsibility for optimizing the supply chain and production processes of this product division. Following the acquisition of AVL Medizintechnik by Roche Diagnostics, as Senior Vice President Global Operations and Site Manager, he was responsible for the integration of the Graz site as well as all business activities in the Roche Group.
Between 1987 and 1995, Ulrich Kanter worked for companies in the Heraeus Group, initially in production management at W.C. Heraeus. From 1989, he held a management role in production planning and production management at Heraeus Instruments, a manufacturer of laboratory equipment including cell incubators (now part of Thermo Fisher Scientific) and lighting systems for operating theaters.
Ulrich Kanter is a graduate mechanical engineer (Berufsakademie Mannheim, Germany). He also completed a course of studies in business administration (Verwaltungs- und Wirtschaftsakademie at the J.W. Goethe University Frankfurt, Germany). He is 51 years old and a German citizen.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions
in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life
sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer
(OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has
manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2013, Tecan generated sales of CHF 388 million
(USD 419 million; EUR 316 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Lesen Sie auch
Tecan Group
Martin Brändle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tecan Group AG via Globenewswire
--- End of Message ---
Tecan Group AG
Seestrasse 103 Maennedorf Switzerland
ISIN: CH0012100191;